Key Facts GPs Should Know About GLP-1 Analogs
Family Medicine Initiative
APRIL 9, 2024
I therefore reviewed the main research studies and guidelines and tried to summarize them briefly and clearly in this article. 4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. How effective are GLP-1 analogs for weight loss?
Let's personalize your content